Key Takeaways

• Emma Walmsley will become HP Inc.’s CEO on 4 January 2027, succeeding interim chief Bruce Broussard.
• Walmsley brings 9 years of CEO experience at GSK (2017‑2025) and 7 years on Microsoft’s board.
• Bruce Broussard will move from interim CEO to Chair of the HP Board on the same date, taking over from current chair Chip Bergh.
• The leadership change follows a period of strategic realignment at HP, mirroring Walma’s transformation record at GSK (specialty medicines focus, R&D revitalisation, balance‑sheet strengthening).

HP Announces New Chief Executive Officer

Background of the Appointment

HP Inc.’s board of directors voted unanimously to install Emma Walmsley as chief executive officer, effective 4 January 2027. The decision ends the interim tenure of Bruce Broussard, who has led the company since February 2026 after the departure of former CEO Antonio Neri. Broussard will transition to Chair of the Board, succeeding Chip Bergh, who has chaired the board since 2017.

Walmasley’s résumé is dominated by a nine‑year stint as Group CEO of GlaxoSmithKline (GSK), where she oversaw the company from April 2017 to December 2025. During that period, GSK’s operating margin rose from 13.5 % to 18.2 %, and the firm’s market‑cap grew by roughly £30 bn after divesting its consumer‑healthcare arm.

In addition to her pharma credentials, Walmsley has been a Microsoft board member since 2017, contributing to governance on a $2.5 trillion enterprise software platform. Prior to GSK, she spent 17 years at L’Oréal, culminating in senior leadership of the global consumer‑goods division.

Leadership Transition Timeline

Comparative Profile: Emma Walmsley vs. Bruce Broussard

Strategic Implications for HP

Walmsley’s track record of portfolio rationalisation and R&D revitalisation aligns with HP’s current focus on high‑margin printing solutions and expanding the PC‑as-a‑service (PCaaS) model. Her experience in balancing a global balance sheet may accelerate HP’s ongoing $1 bn capital‑efficiency program, which aims to lift adjusted EBITDA margin from 12 % to 14 % by FY 2029.

Moreover, her long‑standing relationship with Microsoft could deepen HP’s Windows‑based ecosystem partnerships, potentially unlocking joint‑go‑to‑market initiatives for AI‑enabled devices.

Bottom Line

Emma Walmsley’s appointment signals HP’s intent to import a proven transformation leader from the life‑sciences sector into the technology arena. With a history of boosting operating performance, sharpening strategic focus, and strengthening governance, Walmsley is positioned to steer HP toward higher profitability and deeper ecosystem integration. Simultaneously, Bruce Broussard’s shift to board chair ensures continuity of the cost‑discipline agenda while Chip Bergh steps back after a decade of chairmanship. The leadership overhaul is poised to reshape HP’s growth trajectory over the next five years.

For further details, visit the official HP portal: https://www.hp.com/us-en/home.html.